2024 International Congress Archives - Page 79 of 181

Safety and effectiveness of staged bilateral MR-guided focused ultrasound pallidothalamic tractotomy for motor complications of Parkinson’s disease: study protocol

A. Dalvi, L. Zucker, WC. Chang, PH. Wu, M. Kaplitt, H. Sarva, HM. Eisenberg, P. Fishman, V. Buch, M. Matarazzo, M. Del Alamo, S. Sani, M. Pourfar, A. Mogilner (West Palm Beach, USA)
Safety and efficacy of bilateral magnetic resonance-guided focused ultrasounds (FUS) thalamotomy for refractory essential tremor.

D. Vilas, L. Ispierto, M. Tardáguila, J. Muñoz, A. González, JA. Pérez, R. García, R. álvarez (Badalona, Spain)
Safety and Efficacy of Sublingual Apomorphine in Parkinson’s Patients with or without Concomitant Dopamine Agonists Use

D. Santos Garcia, W. Jost, M. José Martí, M. Fonseca, C. Denecke Muhr, I. Pijuan (A Coruña, Spain)
Safety and Efficacy of the Anti-alpha Synuclein Monoclonal Antibody Lu AF82422 for the Treatment of Patients with MSA: Results from the Phase 2 AMULET Trial

W. Singer, S. Zanigni, L. Kjærsgaard, J. Wiedemann, P. Kallunki, K. Kompus, M. Jørgensen, M. Flensburg, A. Bidani, JL. Molinuevo, A. Takeda, B. Grønning, J. Luthman (Rochester, USA)
Safety and Efficacy of Vatiquinone Treatment in Friedreich Ataxia Patients from MOVE-FA: a Phase 3, Double-blind, Placebo-controlled Trial

D. Lynch, A. Duquette, M. França Jr, S. Perlman, A. Durr, E. Bertini, A. Darling, K. Mathews, L. Schöls, A. Fournier, M. Delatycki, S. Subramony, R. Roxburgh, O. Zhang, C. Rummey, A. Salvucci, B. Yao, J. Cherry, L. Golden, T. Zesiewicz (Philadelphia, USA)
Safety and Tolerability of Bemdaneprocel in People With Parkinson’s Disease: Results up to 24 Months From a Phase 1 Study

H. Sarva, C. Henchcliffe, A. Lozano, A. Fasano, S. Kalia, K. Yu, C. Brennan, W. Stemple, N. Abid, M. Yountz, A. Enayetallah, A. Lampron, V. Tabar (New York, USA)
Safety and Tolerability of Ecopipam in Tourette Syndrome (TS) with Psychiatric Comorbidities.

D. Gilbert, S. Atkinson, G. Karkanias, R. Munschauer, S. Wanaski, T. Cunniff (Cincinnati, USA)
Safety and tolerability of opicapone in Parkinson’s Disease: from early-stage (EPSILON study) to late-stage (BIPARK studies)

G. Cordeiro, I. Peixoto, H. Gama, L. Magalhães, J. Moreira, J-F. Rocha, J. Holenz (Trofa, Portugal)
Safety of Pimavanserin for Parkinson’s Disease Psychosis: Exploratory Analysis of Sedation and Sleep Data From Clinical Studies

A. Berrio, L. Chrones, V. Abler, R. Hauser (San Diego, USA)
Safety of staged bilateral MR-guided focused ultrasound thalamotomy for essential tremor

M. Kaplitt, H. Sarva, V. Krishna, HM. Eisenberg, WJ. Elias, P. Ghanouni, GH. Baltuch, A. Rezai, C. Halpern, B. Dalm, P. Fishman, V. Buch, S. Moosa, AM. Murray (New York, USA)
SAGE-324/BIIB124, an investigational GABAA receptor PAM, for treatment of essential tremor

P. Lewitt, H. Jinnah, R. Pahwa, A. Ellenbogen, R. Kumar, TM. Lieu, B. Hersh, R. Chuang, C. Vaudreuil, Z. Berger, D. Arkilo, SH. Kuo (Bloomfield, USA)
Salford’s Community Based Movement Disorder Service: Providing integrated care for people in their own homes.

T. Jones, C. Miller, C. Lim (Salford, United Kingdom)
Salivary and Plasma Heme Oxygenase-1 Concentration as a New Potential Biomarker in Parkinson Disease

R. Yadav (Kathmandu, Nepal)
SARS-CoV-2 induced neurodegeneration in oxidative stress and genetic models of Parkinson’s Disease

D. Chatterjee, T. Rodriguez, K. Crowther, M. Byrne, R. Smeyne (Philadelphia, USA)
Satisfaction with telemedicine of patients with movement disorders on the Pacific coast of Colombia.

L. Ortega-Bolaños, D. Bolaños-Ortega, K. Ortega-Dorado, K. Martinez-Ortega (Cali, Colombia)
SCN9A Gene Variant in a PD Case with Refractory Dysesthesias

J. Park, B. Barton (Chicago, USA)
Scoping Review of Caregiver Burden in Parkinson’s Disease

S. Luehrsen, I. Pretzer-Aboff, R. Brown (Richmond, USA)
Screening for newly PD-associated RAB32 p.S71R variant in Latin America

M. Rivera Paz, E. Waldo, T. Leal, P. Reyes-Pérez, M. Inca-Martinez, S. Alcauter, I. Amorín, M. Cornejo-Olivas, E. Dieguez, I. Estrada-Bellmann, A. Hernández-Medrano, M. Jimenez-Del-Rio, A. Lescano, B. Muñoz Ospina, K. Nuytemans, J. Orozco, V. Raggio, M. Rentería, J. Rios-Pinto, M. Rodriguez-Violante, K. Salinas Barboza, A. Schuh, C. Velez-Pardo, I. Mata (Cleveland, USA)
Secondary orthostatic tremor associated with hyperthyroidism: A case report

T. Dang, K. Vo, T. Tran (HO CHI MINH, Viet Nam)
Seed Amplification Assay for the differentiation of αSyn seed subtypes

C. Farris, S. Weber, Y. Ma, H. Nguyen, S. Rosete-Gonzalez, A. Siderowf, U. Kang, B. Mollenhauer, L. Concha-Marambio (san diego, USA)
Seeking Traditional Healers in Movement Disorders: a pilot study in two African Countries

T. Roushdy, E. Hamid, N. Salah Adin, A. Mohamed, A. Shalash (Cairo, Egypt)
Selecting an Imaging Biomarker for a Multi-Arm Multi-Stage Trial of Disease-Modifying Treatments for Parkinson’s: The EJS ACT-PD Experience

C. Gonzalez-Robles, S. Al-Bachari, M. Bartlett, R. Petty, S. Collins, R. Ellis-Doyle, G. Mills, P. Piccini, K. Pushparatnam, C. Siu, Z. Walker, M-L. Zeissler, C. Carroll, T. Foltynie, R. Weil, A. Schrag, C. Lambert (London, United Kingdom)
Selective subthalamic DBS improved non-motor disorders without affecting weight gain in parkinsonism

H. Tibar, K A. Charles, F. Naudet, PH. De-Deurwaerdère, A. Benazzouz (Rabat, Morocco)
Self-perception of Health and Depressive Symptomatology in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.

S. Ospina-Otalvaro, C A. Hurtado-Gonzalez, J F. Ayala-Rico, J M. Márquez, M I. Ortiz Agudelo, C O. Moreno, K. Rivera, F. Rojas, S. Guerrero (Cali, Colombia)
SelfCog®: A 15-min Digitized Cognitive Battery To Measure Cognitive Deficit In Parkinson Disease (PD) Patients

J. Montillot, A. Gil-Salcedo, R. Massart, M. Lunven, A. Petit, A. Dormeuil, H. Salhi, A. Bachoud-Lévi, P. Rémy (Créteil, France)
Semantic Memory in Parkinson’s Disease: Linguistic Features and Neural Correlates

F. Toro-Hernández, J. Migeot, N. Marchant, D. Olivares, F. Ferrante, R. González-Gómez, C. González Campo, S. Fittipaldi, G. Rojas-Costa, S. Moguilner, A. Slachevsky, P. Chaná Cuevas, A. Ibáñez, S. Chaigneau, A. García (São Paulo, Brazil)
Seminoma resulting in rapidly progressive cerebellar syndrome with associated dual positive kelch-like protein 11 (KLHL11) IgG and leucine zipper 4 (LUZP4)–immunoglobulin G (IgG) antibodies.

R. Orie, V. Suski, G. Quiroga-Garza, J. Linnoila (Pittsburgh, USA)
Serotonergic dysfunction and impulse control disorders in Parkinson’s disease: a double-tracer PET study

S. Prange, E. Metereau, H. Klinger, M. Hudlestone, N. Costes, S. Lancelot, S. Thobois (Bron, France)
Serotonin Transporter Dynamics in Multiple System Atrophy: Insights from 123I-FP-CIT SPECT Imaging

R. Nagao, H. Watanabe (Toyoake, Japan)
Serum Alpha-Synuclein Levels Are Decreased in Patients with Restless Legs Syndrome and Restored by Intravenous Iron Therapy in Correlation with Ferritin

A. Tahanis, V. Hashem, W. Ondo (Houston, USA)
Serum levels of VEGF-C and ENDGLIN in Parkinson’s disease and their clinical relevance

S. Haji, W. Sako, Y. Osaki, Y. Izumi (Tokushima, Japan)
Serum urea and clinical outcomes in Huntington’s disease

O. Makos, J. Badenoch, M. Hartmann, N. Martin, A. Rangel-Cristales, J. Valera-Bermejo, S. Williams, D. van Wamelen (London, United Kingdom)
Severe Acute Spinal Cord Injury Due to Isolated Generalized Dystonia

A. Eid, J. Perlmutter (Saint Louis, USA)
Severe chorea, ballistic and dystonic movement disorder due to intracerebral hemorrhage in subthalamic nucleus

B. Tserensodnom (Ulaanbaatar, Mongolia)
Severity of Motor Symptoms Correlates with Asymmetric Changes in Globus Pallidus Internus and Caudate Nuclei in Parkinson’s Disease

J. Martinez-Lemus, E. Tharp, T. Ellmore, C. Adams, R. Abuamouneh, E. Rodarte, M. Schiess (Houston, USA)
Sex Cerebral Vasoreactivity Differences in Parkinson’s Disease: Uncovering the Tip of the Iceberg

M. Cansino Torres, D. Ortiz Zacarias, A. Rodríguez Martínez, J. Trejo Ayala, S. Castillo Torres, F. Góngora Rivera, B. Chávez Luévanos, I. Estrada Bellman (Monterrey, Mexico)
Sex Differences for Regional Lewy Body Pathology in Pathologically-Defined Lewy Body Dementia

E. Bayram, D. Coughlin, S. Koga, I. Litvan, D. Dickson (La Jolla, USA)
Sex differences of gait at self-determined speed in neurodegenerative parkinsonism

F. Jagusch, V. Sidoroff, G. Prigent, H. Moradi, S. Sapienza, JP. Ndayisaba, F. Krismer, H. Humer, P. Bachmann, K. Seppi, I. Teckenburg, M. Asalian, D. Benninger, BM. Eskofier, J. Winkler, J. Klucken, H. Gassner, A. Ionescu, K. Aminian, C. Raccagni, GK. Wenning (Innsbruck, Austria)
Sex-Related Differences of Resting-State Brain Activity in Parkinson’s Disease

R. Li, W. Li, Y. Liu (Beijing, China)
Sexual Dimorphism in Clinical Subtypes, Biomarkers and Disease Progression of Parkinson’s Disease

SM. Fereshtehnejad, H. Azizi, J. Lökk, Y. Zeighami (Toronto, Canada)
Shifting Paradigms In Huntington’s Disease Research: A Five-Year Scopus-Based Bibliometric Exploration

RN. Surbakti, RK. Praja (Palangka Raya, Indonesia)
Shifting Tides of Caffeine: Evaluating Consumption Patterns In Parkinson’s disease Progression

S. Bouhadoun, S. Zolfaghari, A. Delva, T. Kouchache, A. Pelletier, R. Postuma (Montréal, Canada)
Simulated Space Gravity Recapitulates Parkinson’s Disease Pathology in Neural Cell Model

V. Lentini, G. Uras, A. Manca, M. El Faqir, S. Lucas, A. Schapira, A. Pantaleo (Sassari, Italy)
Single cell transcriptomics of peripheral blood mononuclear cells and associations with clinical outcomes in Parkinson’s disease

J. Wallin, B. Yaghmaeian Salmani, K. Tiklova, L. Gillberg, H. Green, T. Perlmann, P. Svenningsson (Solna, Sweden)
Skin Tau Quantification as a Novel Biomarker in Huntington’s Disease

I. Ruiz Barrio, A. Vazquez Oliver, A. Puig Davi, E. Rivas Asensio, J. Perez Perez, C. Fernandez Vizuete, A. Horta Barba, G. Olmedo Saura, N. Salvat Rovira, E. Vacchi, G. Melli, J. Pagonabarraga Mora, S. Martinez Horta, J. Kulisevsky (Barcelona, Spain)
Slc2a13, a risk gene for Parkinson’s disease associated with Snca and Lrrk2

JW. Li, GX. Zhang, T. Wang, ZC. Lin, N. Xiong (Wuhan, China)
SLC39A8-CDG with manganese deficiency in an adult individual: a case report

D. Cury Portela, T. Gonçalves Guimarães, G. Sousa Noleto, L. Sousa Araújo, I. Paula, S. Morais, V. Santana Vasconcelos (Teresina, Brazil)
Sleep Characteristics in Idiopathic and Genetic Parkinson’s Disease

A. Astefanous, M. Yang, D. Raymond, M. Rawal, J. Liang, A. Cohen, N. Becker, B. Plitnick, A. Yoo, V. Katsnelson, K. Leaver, S. Bressman, M. Figueiro, R. Saunders-Pullman, A. Wise (NEW YORK, USA)
Sleep disorders in Parkinson’s disease

M. Mirqosimova (Dushanbe, Tajikistan)
Sleep profiles in patients with Essential Tremor and Essential Tremor Plus: Polysomnography Insights

RP. Singh, R. Yadav, P. Pal, R. Mahale, D. Venkata, N. Kamble, V. Holla, J. Saini, B. Kutti, M. Sivasubramanian (Indore, India)
Slow-SPEED-NL: study protocol for a remote trial of exercise for Parkinson’s disease prevention

T. Oosterhof, E. Mitchell, A. Ascherio, B. Bloem, K. van Dijk, B. Dijkstra, L. Kaufmann, R. Lathey, E. Macklin, A. Navangul, A. Pijpers, H. Rowbotham, R. Schneider, M. Schwarzschild, N. de Vries, A. Noyce, S. Darweesh (Nijmegen, Netherlands)
SMaRT-PD: A Clinical Decision Support System for the Management of Parkinson’s Disease

K. Bounsall, K. Hammett, N. Stapleton, R. Hunneman, J. Inches, M. Humphries, J. Warner, S. Bray, E. Meinert, C. Carroll (Plymouth, United Kingdom)
Smartwatch-Based Screening to Identify Candidates for Deep Brain Stimulation in Parkinson’s Disease

R. Fadil, B. Walter, G. Kuhlman, S. Zaidi, D. Heldman (Cleveland, USA)
SNCA Antisense Oligonucleotide for Multiple System Atrophy: HORIZON Trial Update

K. Meilleur, K. Seppi, F. Krismer, R. Simoes, T. Lampreia, J. Corvol, S. Sambin, G. Hoglinger, C. Schindler, A. Schnitzler, C. Hartmann, K. Eggert, H. Pape, A. Ludolph, J. Kassubek, O. Rascol, M. Rumbel, D. Schulz, S. Darrow, Y. Deng, P. Gupta, S. Stanton, J. Esteban, H. Zhao, M. Yarborough, R. Fong (Carlsbad, USA)
Social Media Listening Study to Understand the Journey and Unmet Needs of Patients Living With PSS

S. Carda, J. Wissel, D. Hoad, G. Francisco, M. Verduzco-Gutierrez, D. Gallardo, M. Vacchelli, J. Jacinto (Lausanne, Switzerland)
Social phobia, anxiety and depression in patients with essential tremor

S. Shtaimets, а. Shtraub, N. Zhukova, YU. Lalov, L. Tkachenko, I. Zhukova, A. Agasheva, D. Novotnyy (Omsk, Russian Federation)
Somnolence-Related Events Over Time with Valbenazine Treatment for Chorea Associated with Huntington’s Disease

E. Furr Stimming, D. Claassen, E. Kayson, J. Goldstein, R. Mehanna, S. Hinton, O. Klepitskaya, H. Zhang, S. Karpuram, D. Thai-Cuarto, G. Liang, D. Haubenberger (Houston, USA)
Spastic Ataxia and Motorneuron disease as possible manifestations of ATP13A2 (PARK 9) variants

G. Dalla Zanna, A. Funcis, S. Rossi, F. Santorelli, M. Sabatelli, G. Silvestri (Rome, Italy)
Spastic Ataxia Associated with Congenital Myasthenia Related to the VAMP1 Gene: Report of an Affected Family in Brazil.

J. Balbino, F. Kok, S. Camargos (Belo Horizonte, Brazil)
Spastic paraparesis and paroxysmal dystonia associated with a novel mutation in ATP1A3 in a spanish family

FJ. Azcárate-Díaz, J. Herreros-Rodríguez, L. Llorente-Ayuso, S. Manzano, C. González González, P. Rábano-Suárez, T. Talaván, A. Esquivel (Madrid, Spain)
Spatial Memory and Processing Speed as Cornerstones in Predicting Falls in Parkinson’s Disease

S. Anis, E. Zimmerman, E. Jansen, R. Kaya, H. Fernandez, C. Lopez-Lennon, L. Dibble, A. Rosenfeldt, J. Alberts (Cleveland, USA)
Speaking Out for Speech Therapy: Referral Patterns and Disparities in PD

R. Nitschelm, K. Smith (Worcester, USA)
Spectrum of Movement Disorders in Kazakhstan: Five Years of Insights from Kazakhstan’s First Movement Disorder Center

ZH. Myrzayev, CH. Shashkin, G. Seidakhmetova, B. Abdenov, R. Kaiyrzhanov (Almaty, Kazakhstan)
Spectrum of Movement Disorders in Vitamin B12 Deficiency: A Case Series from India

L. Sahoo, A. Mishra, D. Dash, M. Karan (Bhubaneswar, India)
Spectrum of Movement disorders, Imaging findings in SSPE and response to therapy – A prospective cohort study

A. Elavarasi, D. Dash, M. Tripathi, R. Singh, D. Vibha, A. Garg (New Delhi, India)
Spectrum of Non-HD Hereditary Chorea- Case Series from An Indian Movement Disorder Centre

D. Radhakrishnan, R. Rajan, A. Das, D. Garg, M. Faruq, A. Sonakar, A. Saini, A. Aliyar, J. Parihar, F. Mustafa, E. Arunmozhimaran, S. S, A. Agarwal, A. Pandit, K. Kanojia, Y. Puri, M. Tripathi, A. Srivastava (New Delhi, India)
Spectrum of polysomnographic abnormalities in a cohort of sporadic late onset ataxia patients

A. Das, A. Jaryal, A. Srivastava (New Delhi, India)
Spectrum of Sleep abnormalities in Patients with Progressive supranuclear palsy

M. Nanjunda Swamy, S. Dey, N. Kamble, V. Holla, R. Mahale, P. Pal, M. Debnath, R. Yadav (Bengaluru, India)
Speech Analysis and Machine Learning can Aid in Identifying Different Neurological Disorders

A. Sastre, A. Vaziri, R. Mishra, A. Geronimo, Z. Simmons, J. Adams, A. Pantelyat, A. Wills (Newton, USA)
Speech Biomarkers for Dysarthria in Parkinson’s Disease — Clinical Validation Across two Languages

J. Tröger, E. Baykara, F. Dörr, J. Rusz, J R. Orozco-Arroyave (Saarbrücken, Germany)
Speech features in Korean Parkinson’s disease patients: A prospective cohort study

D. Yoo, S. Cho, J. Kim, J. Bang (Seoul, Republic of Korea)
Speech Processing System for Parkinson’s Disease Using Mixed Reality

M. Wójcik-Pędziwiatr, M. Dudek, W. Skibicka, M. Rudzińska-Bar, M. Danioł, P. Jemioło, J. Stępień, D. Hemmerling (Cracow, Poland)
Sphingomyelinase Activity in Patients with Sporadic Parkinson’s Disease

A. Rekik, A. Mili, S. Naija, E. Jarrar, K. Jemai, A. Hassine, S. Ben Amor, J. Ben Abdallah (Sousse, Tunisia)
Spinal movement disorders in NMOSD, MOGAD, and idiopathic transverse myelitis: a prospective observational study

H. Abboud, R. Sun, N. Modak, M. Elkasaby, A. Wang, M. Levy (Cleveland, USA)
Spinocerebellar Ataxia 34: ELOVL4 Recurrent Mutation in a Different Family

K. Makhoul, R. Ramdhani (Little Neck, USA)
Spinocerebellar ataxia type 2 (SCA2) and Seizures: Is There a Correlation?

P. Bhatia, S. Kaur (Phoenix, USA)
Spinocerebellar ataxia type 2 specific microRNAs may have an effect on neurodegeneration.

R. Singh, V. Swarup, I. Ahmad, V. Anand, I. Singh, M. Faruq, A. Srivastava (NEW DELHI, India)
Spinocerebellar Ataxia Type 4: a Novel Polyglycine Disease caused by GGC Repeat Expansion in ZFHX3.

S. Pulst (slc, USA)
Spinocerebellar Ataxia Type 49 presenting with Early onset Dystonia-Ataxia in an Indian Female

P. Saroja Bylappa, D. Garg, P. Sharma, M. Faruq, A. Agarwal, A. Garg, A. Srivastava (New Delhi, India)
Split-belt Treadmill Training to Rehabilitate Freezing of Gait and Balance in Parkinson’s Disease

S. Sasikumar, A. Fasano, G. Sorrento (Toronto, Canada)
Spray with Nasal Mucoadhesive Microspheres for Treating Parkinsonism.

S. Jain (Gandhinagar, India)
Startle Reflex in CTNNB1 Mutations: A diagnostic Clue

S. Nagaratnam, D. Wilson, M. Garcia, J. Qiu, D. Hadi, S. Mohammad, H. Morales Briceno (Westmead, Australia)
State of happiness as outcome measure in sleep disorders in Parkinson’s disease

I. Murasan, S. Diaconu, L. Ungureanu, R. Filip, L. Irincu, C. Falup-Pecurariu (Brasov, Romania)
Stiff Person Syndrome developing into Corticobasal Syndrome: a case report.

M. Costa, D. Boone, C. Silva, B. Veiga, R. Novais, L. Barcelos, R. Saba, V. Borges, H. Ferraz (São Paulo, Brazil)
Stigmatizing Attitudes Towards People With PD Using The Parkinson’s Disease Social Stigma Perception Scale (PDSP): A Nationwide Study

AL. Guerra-Anzaldo, WF. Moguel-Cardin, A. Domínguez-García, AJ. Hernández-Medrano, G. Rivera-Monroy, K. Velázquez-Román, RJ. Baños-Betancourt, C. álvarez-Hernández, DP. Romero-Terán, KI. Sánchez-Ramírez, M. Rodríguez-Violante, A. Cervantes-Arriaga (Mexico City, Mexico)
STN-DBS Frequency Effects in Parkinson’s: An fMRI Study

A. Vijayakumari, C. Piccinin, J. Alberts, P. Bhattacharya, M. Lowe, B. Walter (Cleveland, USA)
Strategic Training Framework for Advancing Research Capacity through GP2

MT. Perinan, S. Dey, H. Leonard, M. Makarious, A. Martinez-Carrasco, A. Zirra, P. Reyes-Perez, P. Saffie Awad, A. Sanyaolu, P-J. Kung, Y-W. Tay, C. Shambetova, A. Noyce, S. Bandres-Ciga, GP2. Genetics Program (Seville, Spain)
String Vessel Formation Regionally Increases in Long Duration Parkinson’s Disease

D. Dik, GM. Halliday, V. Sytnyk, C. Shepherd (Randwick, Australia)
Structural and Functional Brain Alterations in Laryngeal Dystonia: A Coordinate-Based Activation Likelihood Estimation Meta-Analysis

N. Kshatriya, G. Battistella, K. Simonyan (Boston, USA)
Structural magnetic resonance imaging patterns reflect α-synuclein propagation in a model of Parkinson’s Disease

N. Betrouni, C. Katrib, K. Timmermann, D. Devos, C. Laloux (Lille, France)
Study of Cytokine profile in a Tunisian Parkinson’s Disease cohort

O. Ben Othman, S. Frikha, S. Fezai, A. Achouri, M. Ben Mahmoud, H. Jamoussi, S. Fray, M. Fredj, N. Ben Ali (Tunis, Tunisia)
Study of Relationship Between Homocysteine, Folic Acid And Vitamin B12 Levels In Serum of Juvenile HD Children.

A. Kumar, P. Mishra (Delhi, India)
Study of the functional role of circulating extracellular vesicles as mediators of inflammation in cellular models of Parkinson`s disease

A. Yadav, E. Vacchi, S. Pinton, A. Kaelin-Lang, G. Melli (Bellinzona, Switzerland)
Study of Wearable Technology And Geo-Fencing Device for Quantification of Freezing of Gait And Sleep Pattern In Dystonia Patients In Gurugram City, India

V. Sharma, M. Gautam (Agra, India)
Studying digenic Parkinson’s disease in a stem cell model carrying mutant p.N409S in the GBA1 gene and the homozygous deletion of exon 3 PARK2

C. Oleksy, Z. Hanss, F. Massart, G. Arena, I. Boussaad, R. Krüger (Belvaux, Luxembourg)
Studying monogenic Parkinson’s disease by building a global cohort of mutation carriers

L. Lange, J. Junker, E-J. Vollstedt, K. Roopnarain, M. Doquenia, A. Ahmad-Annuar, M. Avenali, S. Bardien, N. Bahr, M. Ellis, C. Galandra, T. Gasser, P. Heutink, A. Illarionova, Y. Kanana, I. Keller Sarmiento, K. Kumar, S-Y. Lim, H. Madoev, I. Mata, N. Mencacci, M. Nalls, S. Padmanabhan, C. Shambetova, J. Solle, A-H. Tan, J. Trinh, E M. Valente, A. Singleton, C. Blauwendraat, K. Lohmann, Z-H. Fang, C. Klein (Luebeck, Germany)
Sub-insular enlarged perivascular spaces are associated with gait symptom severity and tap response in normal pressure hydrocephalus

J. Ha, S. Lee, S. Kim, JS. Lee, W. Kim, JH. Ahn, JW. Cho, A. Fasano, J. Youn (Seoul, Republic of Korea)
Subacute Combined Degeneration in Wilson Disease: Treatment Dilemma

T. Thammongkolchai, P. Termsarasab (Bangkok, Thailand)
Subdural Hematoma Leading to Subacute Secondary Parkinsonism

G. Ahmadi Jazi, P. Chen, S. Attaripour Isfahani (Orange, USA)
Subgroup Analyses of a Phase 3 Randomized Study of Levodopa/Carbidopa Infusion (ND0612) for Parkinson’s Patients

W. Poewe, A. Espay, N. Lopes, J. Ferreira (Innsbruck, Austria)
Subjective Cognitive Decline in a National Population-based probable RBD Survey

CP. Pauly, SJ. Jónsdóttir, GA. Aguayo, OT. Tsurkalenko, DE. Erz, VS. Schröder, RK. Krüger (Strassen, Luxembourg)
Subjective Sleep Quality and Pathological Sleepiness in Veterans with Parkinson’s Disease

A. Sarwar (PEARLAND, USA)
Substantia Nigra Degeneration In Spinocerebellar Ataxia 2 And 7 Using Neuromelanin-Sensitive Imaging

L. Chougar, G. Coarelli, FX. Lejeune, R. Gaurav, P. Ziegner, A. Durr, S. Lehéricy (PARIS, France)
Subthalamic Local Field Potential Monitoring in Parkinson’s Disease during Epidural Electric Spinal Cord Stimulation

A. Alves, R. Carra, R. Iglesio, L. Silva, D. Soriano, F. Godinho, K. Duarte, M. Teixeira, E. Barbosa, R. Cury (São Paulo, Brazil)
Subthalamic Nucleus Stimulation Modulates Cognitive Theory of Mind in Parkinson’s Disease

HY. Xiao, LQ. Lang, Z. Ye, JJ. Wu (Shanghai, China)
Subtyping Parkinson’s Disease Mild Cognitive Impairment (PD-MCI) by Cholinergic Degeneration

A. Negida, H. Vohra, H. Nawaz, M. Barrett (Henrico, USA)
Suicide risk relationship with motor and non-motor symptoms in patients with Parkinson’s disease.

I. Estrada-Bellmann, A. Ontiveros -Sanchez, R. Trejo-Ayala, G. Porras-Garza, L. Dela Garza, G. Sanchez-Torres, R. Ruiz-Meza, P. Cortes-Estrada (MONTERREY, Mexico)
Superficial siderosis; a case review

ANM. Afifi, L. Satke, E. čecháková (Olomouc, Czech Republic)
Surprising Somatotopy: Buccinator Dyskinesia (Orobuccal Popeye Sign) Induced by Subthalamic Brain Stimulation in Parkinson’s Disease

S. Poveda, T. López, B. Pascual Sedano, I. Aracil Bolaños (Bogotá, Colombia)
Sustained Chorea Improvements with Long-Term, Once-Daily Valbenazine in Adults with Huntington’s Disease

E. Furr Stimming, D. Claassen, E. Kayson, J. Goldstein, R. Mehanna, S. Hinton, O. Klepitskaya, H. Zhang, E. Dunayevich, G. Liang, D. Haubenberger (Houston, USA)
Sustained Effect of Posteroventral Pallidotomy for X-Linked Dystonia Parkinsonism

P. Cataniag, CC. Diesta, JA. Villanueva, JQ. Oropilla (Makati City, Philippines)
Suvecaltamide Metabolites Are CaV3 Modulators and Contribute to Pharmacological Effect

E. Brigham, W. Zeng, N. Shanks, M. Lee (Palo Alto, USA)
Syllable-based speech characteristics as potential biomarker for differential diagnosis of Parkinson’s disease, multiple system atrophy, and cerebellar ataxia

B. Jin, H. Kim, K. Woo, J. Shin (Seoul, Republic of Korea)
Sympathetic Nervous System Overactivity in the Pre-Motor Stage of Parkinson’s Disease: Therapeutic Implications

M. Tagliati, M. Gregorio, H. Maghzi, G. Obialisi, E. Hogg, C. Malatt, E. Tan, M. Kelly, H. Pomeroy, R. Artal, M. Shehata, B. Renner, Z. Fan, P. Sati, G. Pagano (Los Angeles, USA)
Synaptic Density Loss in Parkinson’s Disease Independent of Age: Preliminary Findings using [18F]SynVesT-1 PET Tracer

S. Martin, C. Uribe, K. Desmond, N. Vasdev, A. Strafella (Toronto, Canada)
Syndrome of Progressive Ataxia with Palatal Tremors (PAPT) with Hypertrophied Bilateral Inferior Olives in a young Indian Female

P. Saroja Bylappa, D. Garg, A. Agarwal, A. Garg, A. Srivastava (New Delhi, India)
Systematic Review and Meta-Analysis of Pesticide Exposure and the Risk of Parkinson’s Disease

J. Cheong, ZHK. Goh, H. Frankland, S. Spearman, J. Steinmetz, A. Noyce (London, United Kingdom)
Systematic Review of Incidence and Prevalence Studies of Multiple System Atrophy

B. Benzahia, E. Carter, D. Swallow (Aberdeen, United Kingdom)